Date de l'évènement:
Dimanche, 22 Septembre, 2019
During the 14th EANO annual meeting 3 members of INP team #8 presented their work on Glioma in a plenary conference «CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas» Dominique Figarella Branger, a short talk «Plasmatic differential scanning fluorimetry profiles discriminate glioma patients from healthy controls» Emeline Tabouret and two posters «P11.06: Non epigenetic effect of vorinostat in glioblastoma cells» and «EB1-dependant long survival of glioblastoma cancer stem-like cells tumor-bearing mice after oral treatment with the novel tubular-binding checkpoint activator BAL101553» Raphael Berges.
Romain Appay, member of INP team #8, also attends the conference.
